CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $231,000 | -24.5% | 114,265 | +1.2% | 0.00% | – |
| Q4 2021 | $306,000 | -36.5% | 112,877 | +4.5% | 0.00% | -100.0% |
| Q3 2021 | $482,000 | -21.2% | 107,983 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $612,000 | -14.2% | 105,572 | +4.0% | 0.00% | 0.0% |
| Q1 2021 | $713,000 | +38.2% | 101,528 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $516,000 | -10.1% | 107,436 | +9.1% | 0.00% | 0.0% |
| Q3 2020 | $574,000 | -26.8% | 98,481 | -15.2% | 0.00% | 0.0% |
| Q2 2020 | $784,000 | +84.9% | 116,098 | +74.3% | 0.00% | 0.0% |
| Q1 2020 | $424,000 | -39.1% | 66,594 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $696,000 | +166.7% | 66,788 | +0.5% | 0.00% | – |
| Q3 2019 | $261,000 | -73.6% | 66,483 | -0.1% | 0.00% | -100.0% |
| Q2 2019 | $990,000 | -37.0% | 66,563 | +5.2% | 0.00% | -33.3% |
| Q1 2019 | $1,571,000 | +36.7% | 63,277 | -1.1% | 0.00% | 0.0% |
| Q4 2018 | $1,149,000 | -11.3% | 63,962 | +45.0% | 0.00% | 0.0% |
| Q3 2018 | $1,296,000 | -40.1% | 44,122 | -7.3% | 0.00% | -25.0% |
| Q2 2018 | $2,164,000 | -5.7% | 47,586 | +9.5% | 0.00% | -20.0% |
| Q1 2018 | $2,296,000 | -24.3% | 43,476 | -2.5% | 0.01% | -16.7% |
| Q4 2017 | $3,033,000 | -31.5% | 44,605 | -17.0% | 0.01% | -40.0% |
| Q3 2017 | $4,426,000 | -0.5% | 53,709 | +13.1% | 0.01% | 0.0% |
| Q2 2017 | $4,448,000 | +54.8% | 47,501 | +5.3% | 0.01% | +42.9% |
| Q1 2017 | $2,873,000 | +70.5% | 45,131 | +19.0% | 0.01% | +75.0% |
| Q4 2016 | $1,685,000 | +36.2% | 37,935 | +10.5% | 0.00% | +33.3% |
| Q3 2016 | $1,237,000 | +164.9% | 34,323 | +0.8% | 0.00% | +200.0% |
| Q2 2016 | $467,000 | -21.6% | 34,047 | +9.7% | 0.00% | -50.0% |
| Q1 2016 | $596,000 | -43.7% | 31,027 | +2.6% | 0.00% | -33.3% |
| Q4 2015 | $1,058,000 | -59.4% | 30,237 | +6.6% | 0.00% | -66.7% |
| Q3 2015 | $2,608,000 | +12.0% | 28,357 | +7.0% | 0.01% | +28.6% |
| Q2 2015 | $2,329,000 | +14.5% | 26,506 | -3.3% | 0.01% | +16.7% |
| Q1 2015 | $2,034,000 | +59.4% | 27,406 | +20.3% | 0.01% | +50.0% |
| Q4 2014 | $1,276,000 | +26.3% | 22,786 | +2.4% | 0.00% | +33.3% |
| Q3 2014 | $1,010,000 | +2.1% | 22,261 | -6.8% | 0.00% | 0.0% |
| Q2 2014 | $989,000 | -24.2% | 23,891 | +26.9% | 0.00% | -25.0% |
| Q1 2014 | $1,304,000 | +25.1% | 18,827 | +8.8% | 0.00% | +33.3% |
| Q4 2013 | $1,042,000 | +16.8% | 17,297 | +17.9% | 0.00% | 0.0% |
| Q3 2013 | $892,000 | 0.0% | 14,677 | +10.2% | 0.00% | 0.0% |
| Q2 2013 | $892,000 | – | 13,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |